Enveda Biosciences

Boulder, United States

Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.

$150.0M raised

Sep 2025

Series D

Biotechnology Pharmaceutical Therapeutics

Top Investors

FPV VenturesVillage GlobalLux CapitalSanofiCatalio Capital Management

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Enveda Biosciences

How much funding has Enveda Biosciences raised?

Enveda Biosciences has raised $150.0M in total funding. The most recent round was Series D. The last funding was announced in September 2025.

Who are Enveda Biosciences's investors?

Enveda Biosciences's investors include FPV Ventures, Village Global, Lux Capital, Sanofi, Catalio Capital Management.

Where is Enveda Biosciences headquartered?

Enveda Biosciences is headquartered in Boulder, United States.

What does Enveda Biosciences do?

Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.

What stage is Enveda Biosciences at?

Enveda Biosciences is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 4, 2025.

MLA

"Enveda Biosciences — Funding & Investors." VCBacked, September 4, 2025, https://www.vcbacked.co/company/enveda-biosciences. Accessed June 4, 2026.

APA

VCBacked. (2025). Enveda Biosciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/enveda-biosciences

Wikipedia (cite web)

{{cite web |title=Enveda Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/enveda-biosciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 4, 2025.

Similar Companies in Biotechnology